Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 370

Results For "IMI"

3744 News Found

Biocon receives GMP compliance certificate
Biotech | April 12, 2021

Biocon receives GMP compliance certificate

The company has received a certificate of Good Manufacturing Practice compliance from the Medicines & Healthcare products Regulatory Agency (MHRA) UK


NATCO receives approval for Ibrutinib tablets from ANDA
News | April 11, 2021

NATCO receives approval for Ibrutinib tablets from ANDA

The approval is for Ibrutinib tablets 560 mg, 420 mg, 280 mg and 140 mg strengths


Pharma sector has both brainpower and manpower to drive growth: Mandaviya
Policy | April 09, 2021

Pharma sector has both brainpower and manpower to drive growth: Mandaviya

The government has taken all the effective measures to make healthcare affordable


GlaxoSmithKline approves sale of Vemgal plant
News | April 05, 2021

GlaxoSmithKline approves sale of Vemgal plant

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS


Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI
News | April 05, 2021

Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI

TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India


Reports on GSK Pharmaceuticals by ICICI Securities
News | April 03, 2021

Reports on GSK Pharmaceuticals by ICICI Securities

GSKP announced sale of its newly constructed manufacturing plant at Vemgal, Karnataka to Hetero Labs for a cash consideration of Rs1.8bn


Lonza completes divestment of two sites to NextPharma
News | April 02, 2021

Lonza completes divestment of two sites to NextPharma

Strategic divestment of Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies


Piramal Pharma to acquire 100% stake in Hemmo for Rs 775 Cr
News | April 01, 2021

Piramal Pharma to acquire 100% stake in Hemmo for Rs 775 Cr

This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs


Promoters of Lincoln Pharma increases holding by 4.9%
News | April 01, 2021

Promoters of Lincoln Pharma increases holding by 4.9%

The promoter holding in the company has increased to 37.25%, a rise of 4.9% from 32.35% as of 31 March 2020


Bliss GVS Pharma files suit for IPR infringement
News | March 30, 2021

Bliss GVS Pharma files suit for IPR infringement

The company had filed a suit in the High Court of Justice, Ghana